Kestra Medical Technologies Ltd (KMTS) Q3 2026 Earnings Call Highlights: Robust Revenue Growth ... [Yahoo! Finance]
Kestra Medical Technologies, Ltd. (KMTS)
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Revenue: $24.6 million, a 63% increase compared to the prior year period. Gross Margin: 52.6%, up 9 points year over year and 200 basis points sequentially. Prescriptions: 5,400 prescriptions for the Essure system, a 58% year-over-year increase. GAAP Operating Expenses: $47.7 million, including $1.5 million of non-recurring costs. GAAP Net Loss: $34.2 million, compared to $21.8 million in the prior year period. Adjusted EBITDA Loss: $21.2 million, compared to $16.3 million in the prior year period. Cash Reserves: $291 million as of January 31. Fiscal Year 2026 Revenue Guidance: Increased to $93 million, representing 55% growth compared to fiscal year 2025. Warning! GuruFocus has detected 3 Warning Sign with KMTS. Is KMTS fairly valued? Test your thesis with our free DCF calculator. Release Date: March 17, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive
Show less
Read more
Impact Snapshot
Event Time:
KMTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KMTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KMTS alerts
High impacting Kestra Medical Technologies, Ltd. news events
Weekly update
A roundup of the hottest topics
KMTS
News
- Kestra Medical Technologies (KMTS) had its "buy" rating reaffirmed by BTIG Research. They now have a $32.00 price target on the stock.MarketBeat
- Kestra Medical (KMTS) Q3 2026 Earnings Transcript [Yahoo! Finance]Yahoo! Finance
- Kestra Medical Technologies, Ltd. GAAP EPS of $0.61 beats by $1.21, revenue of $24.55M beats by $1.68M [Seeking Alpha]Seeking Alpha
- Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial ResultsGlobeNewswire
- Kestra Medical Technologies Ltd (KMTS) Q3 2026: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]Yahoo! Finance
KMTS
Earnings
- 3/17/26 - Miss
KMTS
Sec Filings
- 3/19/26 - Form 4
- 3/18/26 - Form S-8
- 3/17/26 - Form 144
- KMTS's page on the SEC website